Monkeypox Market, By Treatment (Cidofovir, Brincidofovir, Tecovirimat, Vaccinia ImmuneGlobulin)

Monkeypox is a type of zoonotic disease that is caused due to transmission of virus from animals to humans. The symptoms correlate quite well with that of small pox. The people of Central and West Africa are more prone to monkeypox. Monkey pox has been witnessed to get transmitted via pet prairie dogs which have been infected with African rodents. The cases of monkeypox have also been reported in Israel, U.K., Nigeria, and others. The specific treatment for monkeypox is not yet available but it can be controlled and prevented by vaccines used for small pox.  

View Detailed Report" https://www.databridgemarketresearch.com/reports/global-monkeypox-market

The monkeypox market is expected to witness significant growth during the forecast period. Rise in risk of zoonotic disease transmission and the growing preference for biological therapies boosted the market growth. In addition, increasing research and development and improved government support also boost market growth. In addition to this, treatment advances and the establishment of well-defined healthcare facilities are some of the major factors for the demand of global monkeypox market. COVID-19 also left a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the monkeypox market in the forecast period 2022-2029. The expected CAGR of global monkeypox market is tend to be around 5.40% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Opportunities

Increasing Demand for Retail Pharmacies

Rise in the number of discovery of therapeutics of monkeypox being delivered through retail pharmacies and rise in retail pharmacies in developed countries create new opportunities for the growth of the global monkeypox market. Additionally, patients preferably choose retail pharmacies for purchasing drugs, due to its easy accessible nature.

Drivers

Rising Prevalence of Monkeypox

The cases of monkeypox are on the rise with each passing day. As per the reports of WHO, since 13 May 2022, and as of 2 June 2022, almost 780 confirmed cases of monkeypox have been witnessed or identified from around 27 Member States. After the outbreak of the disease in 29 May, an increase of 523 laboratory confirmed cases were witnessed. Thus, it boosts the market growth.

Key players operating in the monkeypox market include:

Bavarian Nordic (Denmark)

SIGA Technologies (U.S.)

Chimerix (U.S.)

BioFactura, Inc. (U.S.)

Tonix Pharmaceuticals Holding Corp. (U.S.)

SymBio Pharmaceuticals Limited (Japan)

Gilead Sciences, Inc. (U.S.)

Aspen Holdings (South Africa)

Emcure Pharmaceuticals (India)

Baxter (U.S.)

Grifols S.A. (Spain)

EMERGENT (U.S.)

Hetero (India)

Global Monkeypox Market Scope

The global monkeypox market is segmented on the basis of treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

Cidofovir

Brincidofovir

Tecovirimat

Vaccinia Immune Globulin

End-Users

Clinics

Hospitals

Others

Explore More Reports:

https://dbmrresearchreports.blogspot.com/2024/04/mechanical-security-products-market-to.html

https://dbmrresearchreports.blogspot.com/2024/04/specialties-of-lube-oil-refinery-market.html

https://dbmrresearchreports.blogspot.com/2024/04/acrylic-resin-market-to-reach-usd-2839.html

https://dbmrresearchreports.blogspot.com/2024/04/inorganic-chemical-packaging-market-to.html

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact Us:
Data Bridge Market Research
Tel: US: +1 614 591 3140 |UK: +44 845 154 9652 |APAC: +653 1251 975
Email: Corporatesales@databridgemarketresearch.com

This release was published on openPR.